InMode to Present at Upcoming Investor Conferences and Events

YOKNEAM, Israel, May 13, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events:   Barclays Virtual West Coast Bus Trip Presenters: Yair Malca, Outgoing Chief Financial Officer and Moshik Itzkovich, Senior VP of Finance Format: Virtual investor bus tour When: Wednesday, May 20 Jefferies Global Healthcare Conference Presenters: Yair Malca, Outgoing Chief Financial Officer and Moshik Itzkovich, Senior VP of Finance Format: In-person fireside chat moderated by Matt Taylor, Senior Equity Analyst and one-on-one meetings When: Wednesday, June 3, fireside chat at 12:45 pm ET Location: New York, NY A live webcast of the presentation can be accessed here.

PRNewsWire • May 13, 2026

InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript

InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 6, 2026

InMode Reports First Quarter 2026 Financial Results: Quarterly GAAP Revenue of $82 Million, Represents 5% Year-Over-Year Increase

YOKNEAM, Israel, May 6, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter of 2026.

PRNewsWire • May 6, 2026

Weight-loss revolution sparks new appetite for aesthetics firms

Aesthetic firms are betting that a growing pool of patients experiencing loose skin and facial volume loss from GLP-1 obesity drugs will fuel a new wave of demand, as the sector heads into first-quarter earnings this week.

Reuters • May 4, 2026

InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd.

PRNewsWire • Apr 13, 2026

InMode to Present at the 25th Annual Needham Virtual Healthcare Conference

YOKNEAM, Israel, March 24, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026.

PRNewsWire • Mar 24, 2026

InMode Announces New Share Repurchase Program

YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares outstanding, representing approximately 6.38 million ordinary shares.

PRNewsWire • Mar 13, 2026

InMode Ltd. (INMD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

InMode Ltd. (INMD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Seeking Alpha • Mar 11, 2026

InMode to Present at Upcoming Investor Conferences

YOKNEAM, Israel, Feb. 26, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in March: Barclays 28th Annual Global Healthcare Conference Presenters: Yair Malca, Chief Financial Officer  Format: In-person fireside chat moderated by Matt Miksic, Senior Equity Analyst, and one-on-one meetings Location: Miami, FL When: Wednesday, March 11 at 12:30 pm ET A live webcast of the presentation can be accessed here.

PRNewsWire • Feb 26, 2026

InMode (INMD) Stock Slips As Board Ends Review

The committee, formed by InMode's board, evaluated multiple proposals for a potential transaction with help from outside financial and legal advisers. After reviewing the final bids, it concluded that none were adequate or in the best interests of the company and its shareholders, and decided to discontinue the process.

Benzinga • Feb 23, 2026